Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05174468 · ClinicalTrials.gov registry record
Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy
A clinical trial, sponsored by Breathe BioMedical.
- Terminated
- Registry status
- 28
- Enrollment target
NCT05174468: Clinical Trial study, sponsored by Breathe BioMedical.
NCT05174468 is a clinical trial that was terminated before completion, run by Breathe BioMedical. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05174468 was terminated before completion, sponsored by Breathe BioMedical.
- TERMINATED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The aim of this study is to sample and analyze volatile organic compounds (VOCs) from a high-risk population of subjects eligible for lung cancer screening as defined by the US Preventive Services Task Force (USPSTF) guidelines. The breath sample analysis will help investigators describe and identify real-world breath profiles from individuals at high risk of developing lung cancer and to use this to test machine learning (ML) algorithms for lung cancer screening. This study will also evaluate the feasibility and usability of Picomole's breath sampling technology in a mobile platform. with lung cancer when compared to normal breath profiles using infrared spectroscopy. This work will help validate early proof of concept results conducted with prototype technology and later stage NSCLC breath samples, and inform future breath testing analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2023-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05174468
The ClinicalTrials.gov registry entry for NCT05174468 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Breathe BioMedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05174468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05174468 about?
NCT05174468 is a clinical study titled "Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy". The aim of this study is to sample and analyze volatile organic compounds (VOCs) from a high-risk population of subjects eligible for lung cancer screening as defined by the US Preventive Services Task Force (USPSTF) guidelines. The breath sample analysis will help investigators describe and identif...
What is the current status of trial NCT05174468?
This trial is currently terminated. The enrollment target is 28 participants. The study started on 2022-09-22. Estimated completion is 2023-07-12.
Who is sponsoring clinical trial NCT05174468?
This trial is sponsored by Breathe BioMedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.